Lanzhou University Second Hospital
Clinical trials sponsored by Lanzhou University Second Hospital, explained in plain language.
-
New radioactive compound shows promise in targeting Hard-to-Treat cancers
Disease control CompletedThis early-phase study tested a new radioactive drug called 177Lu-CTR-FAPI in 12 people with advanced solid tumors (breast cancer, sarcoma, or thyroid cancer) that had spread and no longer responded to standard treatments. The main goals were to see if the drug is safe and how it…
Phase: EARLY_PHASE1 • Sponsor: Lanzhou University Second Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New radioactive compound shows promise in first human tests for advanced cancer
Disease control CompletedThis early-phase study tested a new radioactive drug called [177Lu]Lu-TEFAPI-06 in 5 people with advanced solid tumors that had spread and were no longer responding to standard treatments. The main goal was to check safety and see how the drug moves through the body. Researchers …
Phase: EARLY_PHASE1 • Sponsor: Lanzhou University Second Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC